Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06285422
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2024-02-22
Brief Title:
Study Evaluating SC262 in Subjects with Rr Non-Hodgkins Lymphoma VIVID
Sponsor:
Sana Biotechnology
Organization:
Sana Biotechnology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Large B-cell Lymphoma |
| Non Hodgkins Lymphoma |
Keywords:
| Name | View |
|---|---|
| SC262 | View |
| Large B-Cell Lymphoma | View |
| CAR T Cell Therapy | View |
| Mantle Cell Lymphoma | View |
| Follicular Lymphoma | View |
| Marginal Zone Lymphoma | View |
| High-Grade B-Cell Lymphoma | View |
| Primary Mediastinal B-Cell Lymphoma | View |
| Diffuse Large B-Cell Lymphoma | View |
| Non-Hodgkins Lymphoma | View |
| Allogeneic | View |
| Hypoimmune | View |
| CD22 | View |